P 31: Medication intensification strategies and outcomes in patients with type 2 diabetes (T2DM) who have A1C ≥ %7 on ≤ 2 oral anti-diabetes agents (OAD)
Korytkowski, M., MD, Lombardero, M.S., MS, Saul, M., MS, Mori Brooks, M., PhD, Orchard, T.J., MD, M Med Sci, FAHA, FACE, Magaji, V.G., MD, Kanter, J, Siminerio, L., PhD
Published in Diabetes & metabolism (01.11.2012)
Published in Diabetes & metabolism (01.11.2012)
Get full text
Journal Article